Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Inhibin Alpha

Path Created with Sketch.
Go to Inhibin Alpha Normal Tissue GalleryGo back to Product Page
Adrenal gland - Strong INHA immunostaining in all cells of an adrenocortical adenoma.
Adrenal gland – Strong INHA immunostaining in all cells of an adrenocortical adenoma.
Adrenal gland - Strong INHA immunostaining in an adrenocortical carcinoma. Immunostaining is reduced in an area of necrosis.
Adrenal gland – Strong INHA immunostaining in an adrenocortical carcinoma. Immunostaining is reduced in an area of necrosis.
Adrenal gland - Strong INHA immunostaining in most cells of an adrenocortical adenoma. A fraction of cells do not stain, however (mosaic pattern).
Adrenal gland – Strong INHA immunostaining in most cells of an adrenocortical adenoma. A fraction of cells do not stain, however (mosaic pattern).
Adrenal gland - Weak to moderate INHA immunostaining about 70% of the cells of an adrenocortical adenoma.
Adrenal gland – Weak to moderate INHA immunostaining about 70% of the cells of an adrenocortical adenoma.
Breast - INHA negative invasive breast cancer of no special type (NST).
Breast – INHA negative invasive breast cancer of no special type (NST).
Colon - Colorectal adenocarcinoma with focal weak to moderat INHA immunostaining (<5% of cells).
Colon – Colorectal adenocarcinoma with focal weak to moderat INHA immunostaining (<5% of cells).
Esophagus - INHA negative esophageal squamous cell carcinoma.
Esophagus – INHA negative esophageal squamous cell carcinoma.
Kidney - INHA negative clear cell renal cell carcinoma.
Kidney – INHA negative clear cell renal cell carcinoma.
Kidney - Moderate to strong INHA immunostaining in a clear cell renal cell carcinoma.
Kidney – Moderate to strong INHA immunostaining in a clear cell renal cell carcinoma.
Larynx - INHA negative squamous cell carcinoma.
Larynx – INHA negative squamous cell carcinoma.
Liver - Moderate to strong INHA immunostaining in about 50% of the tumor cells of a cholangiocellular carcinoma.
Liver – Moderate to strong INHA immunostaining in about 50% of the tumor cells of a cholangiocellular carcinoma.
Lung - Strong INHA positivity in an adenocarcinoma of the lung.
Lung – Strong INHA positivity in an adenocarcinoma of the lung.
Ovary - INHA negative serous high-grade carcinoma. Scattered stroma cells show strong INHA positivity.
Ovary – INHA negative serous high-grade carcinoma. Scattered stroma cells show strong INHA positivity.
Pancreas - INHA negative adenocarcinoma.
Pancreas – INHA negative adenocarcinoma.
Pancreas - Moderate to strong INHA immunostaining in a pancreatic acinar cell carcinoma.
Pancreas – Moderate to strong INHA immunostaining in a pancreatic acinar cell carcinoma.
Pancreas - Strong INHA immunostaining in the vast majority of the tumor cells of a neuroendocrine tumor.
Pancreas – Strong INHA immunostaining in the vast majority of the tumor cells of a neuroendocrine tumor.
Penis - INHA positivity of variable intensity (mosaic pattern) in a penile squamous cell carcinoma.
Penis – INHA positivity of variable intensity (mosaic pattern) in a penile squamous cell carcinoma.
Prostate - INHA negative prostatic adenocarcinoma (Gleason 3+3=6).
Prostate – INHA negative prostatic adenocarcinoma (Gleason 3+3=6).
Skin - INHA negative Merkel cell carcinoma.
Skin – INHA negative Merkel cell carcinoma.
Soft tissues - Granular cell tumor with strong INHA immunostaining.
Soft tissues – Granular cell tumor with strong INHA immunostaining.
Stomach - INHA negative gastric adenocarcinoma.
Stomach – INHA negative gastric adenocarcinoma.
Testis - INHA negative seminoma.
Testis – INHA negative seminoma.
Thyroid - INHA negative papillary carcinoma.
Thyroid – INHA negative papillary carcinoma.
Urinary bladder - INHA negative muscle-invasive urothelial carcinoma.
Urinary bladder – INHA negative muscle-invasive urothelial carcinoma.
Urinary bladder - Muscle-invasive urothelial carcinoma with focal strong INHA immunostaining (<5% of cells).
Urinary bladder – Muscle-invasive urothelial carcinoma with focal strong INHA immunostaining (<5% of cells).
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors